New World Medical registers KDB GLIDE with FDA

Posted on

The KDB GLIDE (New World Medical) has been registered with the U.S. Food and Drug Administration as a Class 1 device, according to a press release.

The device improves on Kahook Dual Blade technology and is designed for surgeons performing excisional goniotomy for treatment of glaucoma.

“New World Medical is dedicated to preventing vision loss from glaucoma, the leading cause of irreversible blindness worldwide, through continuous, industry-leading innovation. We’re very excited to launch KDB GLIDE, giving surgeons more features that provide a smooth and elegant approach to the trusted goniotomy procedure,” said Bilal Khan, Chief Executive Officer at New World Medical in the press release.

KDB GLIDE will be available for purchase in the United States soon, according to the company.

Read the full press release here.

Related Articles
IOP outcomes after laser trabeculoplasty in eyes with prior Kahook Dual Blade goniotomy limited
Jul 28, 2021
Hydrus microstent reduces IOP, medication burden
Jul 26, 2021
IOP, gel microstents complications leading cause of reoperation after MIGS
Jul 23, 2021